FibroBiologics, Inc. (FBLG)

Profile

Full Name

FibroBiologics, Inc.

Ticker

NASDAQ: FBLG

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 1, 2024

Indexes

Not included

Website

https://www.fibrobiologics.com

Employees

13

Key Details

Price

$0.24(-8.44%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$0.34(49.71% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.24
    FBLG price is $0.24

    30-Day Relative Volume

    1.80
    FBLG 30-day relative volume is 1.80

    Price Performance

    Price 1-Day Change

    -8.44%
    FBLG price is down -8.44% today

    Price YTD Change

    -87.96%
    FBLG price is down -87.96% since January 1st

    Price 1-Year Change

    -88.85%
    FBLG price is down -88.85% year-on-year

    Price 3-Year Change

    -
    FBLG price 3-year change is unknown

    Price Range

    Price All-Time High

    $55.00
    FBLG price is currently -99.56% below its historical high of $55.00

    Price 3-Year Low

    $0.24
    FBLG price is currently +2.34% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $12.39M
    FBLG market cap is $12.39 million

    Market Cap 3-Year Change

    -
    FBLG market cap 3-year change is unknown

    Market Cap All-Time High

    $945.52M
    FBLG market cap is currently -98.69% below its historical high of $945.52 million

    Market Cap Sector Percentile

    19.97%
    FBLG market cap is higher than 19.97% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +48.46%
    FBLG shares outstanding is up +48.46% year-on-year

    Shares Outstanding 3-Year Change

    +58.36%
    FBLG shares outstanding is up +58.36% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.75
    FBLG beta is 0.75

    200-day SMA

    $0.68
    FBLG price is currently -64.47% below its 200-day simple moving average

    50-day SMA

    $0.36
    FBLG price is currently -32.68% below its 50-day simple moving average

    14-Day RSI

    39.69
    FBLG 14-day relative strength index is 39.69

    Volume

    1.80
    FBLG 30-day relative volume is 1.80

    ATR

    $0.05
    FBLG average true range is $0.05

    10-day Historical Volatility

    209.68%
    FBLG 10-day historical volatility is 209.68%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    FBLG annual revenue is $0.00

    Revenue Analysts Estimate

    -
    FBLG annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    FBLG annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.27%
    FBLG annual revenue is higher than 28.27% of companies in Healthcare sector

    EPS

    EPS

    -$0.34
    FBLG annual earnings per share is -$0.34

    EPS Analysts Estimate

    -$0.48
    FBLG annual earnings per share is currently +30.00% higher than the consensus analysts' forecast

    EPS 1-Year Change

    +49.71%
    FBLG annual earnings per share is up +49.71% year-on-year

    EPS Sector Percentile

    71.93%
    FBLG annual earnings per share is higher than 71.93% of companies in Healthcare sector

    Profit

    Gross Profit

    -$573.00K
    FBLG annual gross profit is -$573.00 thousand

    Gross Margin

    -
    FBLG annual gross profit margin value is unknown

    Operating Profit

    -$13.74M
    FBLG annual operating income is -$13.74 million

    Operating Margin

    -
    FBLG annual operating profit margin value is unknown

    Net Income

    -$11.16M
    FBLG annual net profit is -$11.16 million

    Net Margin

    -
    FBLG annual net profit margin value is unknown

    Expenses

    Total Expenses

    $13.74M
    FBLG annual total expenses is $13.74 million

    Operating Expenses

    $13.74M
    FBLG annual total operating expenses is $13.74 million

    Cost Of Goods Sold

    $573.00K
    FBLG annual cost of goods sold is $573.00 thousand

    Selling, General & Administrative Expenses

    $9.23M
    FBLG annual SG&A is $9.23 million

    Depreciation & Amortization

    $573.00K
    FBLG annual D&A is $573.00 thousand

    Interest Expense

    $20.00K
    FBLG annual interest expense is $20.00 thousand

    Income Tax

    $0.00
    FBLG annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$11.14M
    FBLG annual earnings before interest & taxes is -$11.14 million

    EBITDA

    -$10.57M
    FBLG annual EBITDA is -$10.57 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $22.12M
    FBLG annual total assets is $22.12 million

    Non Current Assets

    $2.22M
    FBLG annual long term assets is $2.22 million

    Current Assets

    $14.23M
    FBLG annual total current assets is $14.23 million

    Cash and Cash Equivalents

    $13.98M
    FBLG annual cash & cash equivalents is $13.98 million

    Accounts Receivable

    -
    FBLG annual accounts receivable value is unknown

    Inventory

    $0.00
    FBLG annual inventory is $0.00

    Liabilities

    Total Liabilities

    $19.39M
    FBLG annual total liabilities is $19.39 million

    Long Term Liabilities

    $984.00K
    FBLG annual total long term liabilities is $984.00 thousand

    Current Liabilities

    $12.73M
    FBLG annual current liabilities is $12.73 million

    Accounts Payable

    $2.70M
    FBLG annual accounts payable is $2.70 million

    Debt

    Total Debt

    $10.55M
    FBLG annual total debt is $10.55 million

    Total Debt 1-Year Change

    +504.06%
    FBLG annual total debt is up +504.06% year-on-year

    Long Term Debt

    $984.00K
    FBLG annual long term debt is $984.00 thousand

    Short Term Debt

    $9.57M
    FBLG annual short term debt is $9.57 million

    Equity & Capital

    Shareholders Equity

    $2.73M
    FBLG annual stockholders equity is $2.73 million

    Book Value

    $2.73M
    FBLG annual book value is $2.73 million

    Retained Earnings

    -$35.52M
    FBLG annual retained earnings is -$35.52 million

    Working Capital

    $1.50M
    FBLG annual working capital is $1.50 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$11.90M
    FBLG annual cash from operations is -$11.90 million

    Cash From Operations 1-Year Change

    -85.92%
    FBLG annual cash from operations is down -85.92% year-on-year

    Cash From Investing

    -$184.00K
    FBLG annual cash from investing is -$184.00 thousand

    Cash From Investing 1-Year Change

    +62.83%
    FBLG annual cash from investing is up +62.83% year-on-year

    Cash From Financing

    $16.91M
    FBLG annual cash from financing is $16.91 million

    Cash From Financing 1-Year Change

    +22.58%
    FBLG annual cash from financing is up +22.58% year-on-year

    CAPEX

    CAPEX

    $184.00K
    FBLG annual capital expenditures is $184.00 thousand

    CAPEX 1-Year Change

    -62.83%
    FBLG annual capital expenditures is down -62.83% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$12.09M
    FBLG annual free cash flow is -$12.09 million

    Free Cash Flow 1-Year Change

    -75.25%
    FBLG annual free cash flow is down -75.25% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    FBLG annual gross profit margin value is unknown

    Operating Margin

    -
    FBLG annual operating profit margin value is unknown

    Net Margin

    -
    FBLG annual net profit margin value is unknown

    ROA & ROE

    ROA

    -65.76%
    FBLG annual return on assets is -65.76%

    ROE

    -559.73%
    FBLG annual return on equity is -559.73%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    FBLG price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    FBLG price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    99.13
    FBLG price to book ratio is 99.13

    PB Ratio Sector Percentile

    98.58%
    FBLG price to book ratio is higher than 98.58% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    FBLG price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    FBLG price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $14.64M
    FBLG enterprise value is $14.64 million

    Enterprise Value Sector Percentile

    24.27%
    FBLG enterprise value is higher than 24.27% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.86
    FBLG EV/EBITDA is -0.86

    EV/EBITDA Sector Percentile

    48.48%
    FBLG EV/EBITDA is higher than 48.48% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    1.12
    FBLG annual current ratio is 1.12

    Quick Ratio

    1.12
    FBLG annual quick ratio is 1.12

    Leverage

    Debt To Equity

    3.86
    FBLG annual debt to equity ratio is 3.86

    Interest Coverage Ratio

    -557.05
    FBLG annual interest coverage ratio is -557.05

    Risk & Stability

    F-Score

    -
    FBLG piotroski f-score value is unknown

    Altman Z-Score

    -3.44
    FBLG altman z-score is -3.44

    Analyst ratings

    Recent major analysts updates

    Nov 20, 25 D. Boral Capital
    Buy
    Nov 5, 25 HC Wainwright & Co.
    Buy
    Nov 3, 25 D. Boral Capital
    Buy
    Sep 12, 25 HC Wainwright & Co.
    Buy
    Sep 10, 25 D. Boral Capital
    Buy
    Aug 5, 25 HC Wainwright & Co.
    Buy
    Aug 4, 25 D. Boral Capital
    Buy
    Jul 29, 25 D. Boral Capital
    Buy
    Jul 9, 25 D. Boral Capital
    Buy
    Jun 17, 25 D. Boral Capital
    Buy

    Institutional Ownership

    Screeners with FBLG included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for FibroBiologics, Inc.?
    • Does FibroBiologics, Inc. pay dividends?
    • What sector is FibroBiologics, Inc. in?
    • What industry is FibroBiologics, Inc. in?
    • What country is FibroBiologics, Inc. based in?
    • When did FibroBiologics, Inc. go public?
    • Is FibroBiologics, Inc. in the S&P 500?
    • Is FibroBiologics, Inc. in the NASDAQ 100?
    • Is FibroBiologics, Inc. in the Dow Jones?
    • When was FibroBiologics, Inc.'s last earnings report?
    • When does FibroBiologics, Inc. report earnings?

    What is the ticker symbol for FibroBiologics, Inc.?

    The ticker symbol for FibroBiologics, Inc. is NASDAQ:FBLG

    Does FibroBiologics, Inc. pay dividends?

    No, FibroBiologics, Inc. does not pay dividends

    What sector is FibroBiologics, Inc. in?

    FibroBiologics, Inc. is in the Healthcare sector

    What industry is FibroBiologics, Inc. in?

    FibroBiologics, Inc. is in the Biotechnology industry

    What country is FibroBiologics, Inc. based in?

    FibroBiologics, Inc. is headquartered in United States

    When did FibroBiologics, Inc. go public?

    FibroBiologics, Inc.'s initial public offering (IPO) was on February 1, 2024

    Is FibroBiologics, Inc. in the S&P 500?

    No, FibroBiologics, Inc. is not included in the S&P 500 index

    Is FibroBiologics, Inc. in the NASDAQ 100?

    No, FibroBiologics, Inc. is not included in the NASDAQ 100 index

    Is FibroBiologics, Inc. in the Dow Jones?

    No, FibroBiologics, Inc. is not included in the Dow Jones index

    When was FibroBiologics, Inc.'s last earnings report?

    FibroBiologics, Inc.'s most recent earnings report was on August 14, 2025

    When does FibroBiologics, Inc. report earnings?

    The date for FibroBiologics, Inc.'s next earnings report has not been announced yet
    On this page